Gadoteridol

Gadoteridol

Systematic (IUPAC) name
gadolinium(+3) cation; 2-[4-(2-hydroxypropyl)-7,10-bis(2-oxido-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Routes of administration	IV
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	120066-54-8
ATC code	V08CA04 (WHO)
PubChem	CID 60714
DrugBank	DB00597
ChemSpider	54719
UNII	0199MV609F
KEGG	D01137
ChEBI	CHEBI:31643
ChEMBL	CHEMBL1200593
Synonyms	(10-(2-(hydroxy-κO)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3^−)-κN1,κN4,κN7,κN10,κO1,κO4,κO7)-gadolinium
Chemical data
Formula	C17H29GdN4O7
Molar mass	558.68 g/mol
SMILES [Gd+3].[O-]C(=O)CN1CCN(CCN(CCN(CC(O)C)CC1)CC([O-])=O)CC([O-])=O
InChI InChI=1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 Key:DPNNNPAKRZOSMO-UHFFFAOYSA-K
(what is this?)  (verify)

Gadoteridol (INN) is a gadolinium-based MRI contrast agent, used particularly in the imaging of the central nervous system. It is sold under the brand name ProHance.

References

• Bracco Diagnostic Inc. (May 2007). "Gadoteridol (ProHance) prescribing information (revised May 2007)". DailyMed. U.S. National Library of Medicine. Retrieved 2008-07-13.